World's Best Scientists 2026 revealed!
Anthony J. Windebank

Anthony J. Windebank

D-Index & Metrics

Medicine

D-Index
89
Citations
27493
World Ranking
12747
National Ranking
6514

Anthony J. Windebank publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Anthony J. Windebank sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 352 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Anthony J. Windebank D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Anthony J. Windebank sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Anthony J. Windebank is affiliated with the Mayo Clinic in the United States. Their research primarily focuses on the field of Medicine, encompassing subfields such as Pathology and Forensic Medicine, Genetics, Surgery, Cellular and Molecular Neuroscience, and Molecular Biology.

The scientist's main topics of investigation include nerve injury and regeneration, spinal cord injury research, mesenchymal stem cell research, nerve injury and rehabilitation, amyotrophic lateral sclerosis (ALS) research, electrospun nanofibers in biomedical applications, and neurogenetic and muscular disorders research.

Anthony J. Windebank has contributed to a range of recent papers, demonstrating active involvement in clinical and translational neuroscience and regenerative medicine. Some of the notable publications are:

  • A randomized placebo-controlled phase 3 study of mesenchymal stem cells induced to secrete high levels of neurotrophic factors in amyotrophic lateral sclerosis (2021, Muscle & Nerve)
  • Addressing heterogeneity in amyotrophic lateral sclerosis clinical trials (2020, Muscle & Nerve)
  • Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial (2024, Nature Communications)
  • Segment-Specific Orientation of the Dorsal and Ventral Roots for Precise Therapeutic Targeting of Human Spinal Cord (2021, Mayo Clinic Proceedings)
  • The evolving regulatory landscape in regenerative medicine (2022, Molecular Aspects of Medicine)

The researcher frequently collaborates with colleagues such as Nicolas N. Madigan, Ahad M. Siddiqui, Jarred J. Nesbitt, Riazul Islam, and Igor Lavrov. These collaborations underscore interdisciplinary work spanning neuroscience and regenerative therapies.

Anthony J. Windebank's work appears regularly in respected venues, with frequent publications in journals such as:

  • Neurology
  • Muscle & Nerve
  • Mayo Clinic Proceedings
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Spine Journal

The research covers experimental approaches and clinical trials, particularly related to neurological diseases and injuries. This includes the use of mesenchymal stem cells as therapeutic agents in conditions like ALS and spinal cord injury, as well as strategies for targeting the human spinal cord with precision. The corpus of work provides insight into cellular and molecular mechanisms underlying nerve repair and neurodegeneration, contributing to evolving treatment paradigms in regenerative medicine.

Best Publications

  • Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome.

    Herbert Schaumburg;Jerry Kaplan;Anthony Windebank;Nicholas Vick

  • Chemotherapy-induced neuropathy.

    Anthony J. Windebank;Wolfgang Grisold

  • Calcium-Channel Antibodies in the Lambert–Eaton Syndrome and Other Paraneoplastic Syndromes

    Vanda A. Lennon;Thomas J. Kryzer;Guy E. Griesmann;Padraig E. O'Suilleabhain

  • Chemotherapy-induced peripheral neuropathy: A current review

    Nathan P. Staff;Anna Grisold;Wolfgang Grisold;Anthony J. Windebank

  • A biomaterials approach to peripheral nerve regeneration: bridging the peripheral nerve gap and enhancing functional recovery

    W. Daly;L. Yao;Dimitrios I. Zeugolis;A. Windebank

  • Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy.

    Peter James Dyck;Jasper Daube;Peter O'brien;Alvaro Pineda

  • Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment

    Peter James Dyck;Peter C. O'Brien;Karen F. Oviatt;Robert P. Dinapoli

  • A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy

    Peter James Dyck;William J. Litchy;Kay M. Kratz;Guillermo A. Suarez

  • Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention

    Wolfgang Grisold;Guido Cavaletti;Anthony J. Windebank

  • NEURONS UNDERGO APOPTOSIS IN ANIMAL AND CELL CULTURE MODELS OF DIABETES

    James W. Russell;Kelli A. Sullivan;Anthony J. Windebank;David N. Herrmann

  • Designing ideal conduits for peripheral nerve repair.

    Godard C. W. de Ruiter;Martijn J. A. Malessy;Michael J. Yaszemski;Anthony J. Windebank

  • Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: New insights into pathophysiology and treatment

    P. James B. Dyck;Anthony J. Windebank

  • NONSYSTEMIC VASCULITIC NEUROPATHY

    Peter James Dyck;Timothy J. Benstead;Doyt L. Conn;J. Clarke Stevens

  • The Rochester Diabetic Neuropathy Study Design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests

    P. J. Dyck;K. M. Kratz;K. A. Lehman;J. L. Karnes

  • 3,4-Diaminopyridine in the Treatment of Lambert-Eaton Myasthenic Syndrome

    Kathleen M. McEVOY;Anthony J. Windebank;Jasper R. Daube;Phillip A. Low

  • Multiple-channel scaffolds to promote spinal cord axon regeneration.

    Michael J. Moore;Jonathan A. Friedman;Eric B. Lewellyn;Sara M. Mantila

  • Cisplatin induced Mitochondrial DNA damage in dorsal root ganglion neurons

    Jewel L. Podratz;Andrew M. Knight;Lauren E. Ta;Nathan P. Staff

  • Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance.

    Peter James Dyck;Phillip A. Low;Anthony J. Windebank;Safwan S. Jaradeh

  • Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum–DNA binding

    Lauren E. Ta;Laura Espeset;Jewel Podratz;Anthony J. Windebank

  • Cisplatin-induced apoptosis in rat dorsal root ganglion neurons is associated with attempted entry into the cell cycle.

    Jagjit S. Gill;Anthony J. Windebank

Frequent Co-Authors

Peter J. Dyck
Peter J. Dyck Mayo Clinic
Lichun Lu
Lichun Lu Mayo Clinic
Phillip A. Low
Phillip A. Low Mayo Clinic
Abhay Pandit
Abhay Pandit University of Galway
Timothy O'Brien
Timothy O'Brien University of Minnesota
Vanda A. Lennon
Vanda A. Lennon Mayo Clinic
Eva L. Feldman
Eva L. Feldman University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare careers or expanding your qualifications has never been more accessible, thanks to a wide range of online programs. For those considering a nursing career, online nursing school options provide flexible pathways to start or advance in nursing, accommodating busy schedules and diverse backgrounds.

Cost-conscious students can consider the cheapest phd nursing programs to gain advanced research and leadership skills without overwhelming debt. Similarly, registered nurses who want to progress in the field might explore the cheapest rn to bsn programs to boost their credentials affordably and efficiently.

For those with a non-nursing bachelor’s degree, direct entry msn programs online offer a fast-track route to a master’s in nursing, opening doors to advanced practice and leadership roles. Whichever path you choose, online healthcare degrees can help you tailor your education to fit your career goals, budget, and timeline.

Best Scientists Citing Anthony J. Windebank

Trending Scientists

Recently Published Articles